Skip to main content
Fig. 4 | Diagnostic Pathology

Fig. 4

From: Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis

Fig. 4

Kaplan-Meier curves for disease-specific survival (DSS) and progression-free survival (PFS) according to the expression levels of TWIST1 in colorectal cancer. (Nuclear and cytoplasmic TWIST1 expression in tumor cells was divided into two groups as follows: high and low expression levels). a Log Rank test showed that patients with a high nuclear TWIST1 expression had shorter DSS and b PFS compared to patients with a low nuclear TWIST1 expression (P = 0.042 and P = 0.043, respectively). c, d The Kaplan–Meier survival analysis showed that there were no significant differences in terms of survival (DSS and PFS) between patients with high and low cytoplasmic TWIST1 expressions (Survival analysis: DSS (P = 0.320) and PFS (P = 0.320))

Back to article page